Michael Grissinger
Director, Adicet Bio, Inc.
Companies
- Lipocine Inc.Board member Aug 7, 2026 to now1
- Aprea Therapeutics, Inc.Board member May 26, 2022 to now2
- Adicet Bio, Inc.Board member Nov 6, 2018 to now3
- Akari Therapeutics PlcBoard member Jan 2, 2024 to Jul 2, 20244
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Akari Therapeutics Plc AKTX20,000,000 shares5$167.4M at $8.37Jan 2, 2024
- Aprea Therapeutics, Inc. APRE6,024 shares6$3.5K at $0.58Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 3,135 shares of Aprea Therapeutics, Inc.6
- Jun 5, 2025Granted 1,045 shares of Aprea Therapeutics, Inc.7
- Jun 20, 2024Granted 1,045 shares of Aprea Therapeutics, Inc.8
- Aug 23, 2023Granted 500 shares of Aprea Therapeutics, Inc.9
- Jul 28, 2022Granted 5,995 shares of Aprea Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLipocine Inc., Board member
- 2
- 3SEC EDGARAdicet Bio, Inc., Board member
- 4SEC EDGARAkari Therapeutics Plc, Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 9, 2025
- 8SEC EDGARForm 4 filed Jun 21, 2024
- 9SEC EDGARForm 4 filed Aug 24, 2023
- 10SEC EDGARForm 4 filed Aug 1, 2022